| | POLISH FINANCIAL SUPERVISION AUTHORITY | |
| |
| | | UNI - EN REPORT No | 98 | / | 2012 |
| | |
| | Date of issue: | 2012-10-05 | | | | | | | | |
| | Short name of the issuer | | | | | | | |
| | SOPHARMA AD | |
| | Subject | | | | | | | | | | |
| | Sopharma monthly September 2012 | |
| | Official market - legal basis | | | | | | |
| | Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
| |
| | Unofficial market - legal basis | | | | | |
| | Contents of the report: | | | | | | | | |
| | The Board of Directors of Sopharma AD (the “Company") notifies that for September 2012 sales revenues remained at the same level compared to the same period of 2011, including 9% decrease of domestic sales and 4% increase of export sales.
During the first nine months of this year Sopharma AD realized an increase of sales revenues of 2%, including 10% decrease of domestic sales and 7% increase of export sales compared to the same period of 2011.
| |
| | Annexes | | | | | | | | | | |
| | File | Description | |
| | Sopharma monthly September 2012 .doc | Sopharma monthly September 2012 | |
